These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31712163)

  • 1. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
    Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC
    Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
    Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
    Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
    Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.
    Liang L; Huang J
    Oncol Rep; 2016 Sep; 36(3):1333-8. PubMed ID: 27430890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.
    Wu S; Huang J; Hui K; Yue Y; Gu Y; Ning Z; Wang X; He D; Wu K
    Oncol Rep; 2018 Nov; 40(5):2836-2843. PubMed ID: 30226607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
    Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
    Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
    Yar Saglam AS; Kayhan H; Alp E; Onen HI
    Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
    Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
    Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
    Chen KY; Chen CC; Chang YC; Chang MC
    PLoS One; 2019; 14(7):e0219317. PubMed ID: 31310624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.